Study: 4 in 10 adults with chronic pain report depression, anxiety
Approximately 40 percent of adults with chronic pain experience depression or anxiety, according to a review published online March 7 in JAMA Network Open.
Study finds GLP-1 receptor agonists target fat over muscle for weight loss
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have shown significant effectiveness in both lowering blood sugar levels and aiding weight loss due to their unique pharmacological mechanisms.
Intermittent fasting aids weight loss and boosts heart health in obesity, study finds
A team of scientists has shown that intermittent fasting (reducing the number of hours of intake and extending the hours of fasting each day) is an effective method for losing weight and improves cardiovascular health in people with obesity problems.
Adopting a healthier lifestyle could help manage lower back pain
Low back pain is a leading cause of disability worldwide with many treatments, such as medication, often failing to provide lasting relief. Researchers from the University of Sydney's Center for Rural Health have uncovered a possible solution. Their study, published in JAMA Network Open, found integrating lifestyle support into back pain care could reduce disability and enhance quality of life.
GLP-1 RAs efficacious for weight loss in overweight, obesity without diabetes
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published online Jan. 7 in the Annals of Internal Medicine.